{"id":"W4235321914","doi":"10.21203/rs.2.21605/v1","title":"Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; Health Sciences Centre; Canadian Partnership Against Cancer; Canadian Agency for Drugs and Technologies in Health; Sunnybrook Health Science Centre; Queen's University; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Government of Ontario; Canadian Centre for Applied Research in Cancer Control; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Ipilimumab; Metastatic melanoma; Medicine; Oncology; Cohort; Melanoma; Comparative effectiveness research; Real world evidence; Internal medicine; Cohort study; Demography; Cancer; Immunotherapy; Alternative medicine; Cancer research; Pathology; Sociology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001810345,0.000394071,0.0007385014,0.0008257349,0.001792696,0.001170163,0.001344743,0.000498037,0.001532739],"category_scores_gemma":[0.00400625,0.0003867515,0.001220223,0.003297617,0.0008974714,0.0003400542,0.0006856527,0.0006916997,0.0001233776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03398427,"about_ca_system_score_gemma":0.02585842,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9813058,"about_ca_topic_score_gemma":0.9844955,"domain_scores_codex":[0.9976199,0.0003971318,0.0002264337,0.0005623432,0.0006547119,0.0005394892],"domain_scores_gemma":[0.994777,0.0004659229,0.002051494,0.0003627343,0.001393706,0.0009490679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003584814,0.00003897872,0.9959548,0.00007172285,0.0003751699,0.00008910846,0.0002919136,0.000153591,0.0001421259,0.0001137171,0.0008532266,0.001557316],"study_design_scores_gemma":[0.00009965942,0.00008545118,0.9976462,0.00004415693,0.0002119971,0.00008456695,0.0003788625,0.0004600012,0.00005217482,0.00003492315,0.0008870777,0.00001495052],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908797,0.001402493,0.0001795399,0.000383146,0.00001615351,0.0001072027,0.005970653,0.000007091975,0.00105407],"genre_scores_gemma":[0.9977944,0.0003348539,0.0001361569,0.0001109797,0.00001058645,0.00003322159,0.001326536,0.000003034761,0.0002503078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03398427,"threshold_uncertainty_score":0.2465743,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1057925294728571,"score_gpt":0.4238886071689379,"score_spread":0.3180960776960808,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}